ArticleFrontiers in oncology2023

All-oral low-dose chemotherapy TEPIP is effective and well-tolerated in patients with peripheral T-cell lymphoma.

Matthias A Fante et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.